Infinity Pharmaceuticals News Breakdown

INFI -- USA Stock  

USD 2.05  0.33  19.19%

Macroaxis does not monitor all media channels or aggregates social signals for Infinity Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Infinity Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Infinity Pharmaceuticals. Please also check Infinity Pharmaceuticals Hype Analysis, Infinity Pharmaceuticals Correlation and Infinity Pharmaceuticals Performance.
  
3 days ago at www.thestocksnews.com         
Monthly loser Infinity Pharmaceuticals, Inc. stock performed -15.27 percent down
news
The Stocks News Get full coverage
  
  
few days ago at www.macroaxis.com         
Purchase by Bvf Partners L P of 36825 shares of Infinity Pharmaceuticals
Macroaxis News
Filed transaction by Infinity Pharmaceuticals executive. General open market or private purchase of non-derivative or derivative security
  
  
few days ago at fintelegraph.com         
Staying ahead of the game Celsion Corporation , Infinity Pharmaceuticals, Inc.
news
Financial Telegraph Get full coverage
  
  
few days ago at nasdaqplace.com         
News Report of Sizzling Healthcare Stock Infinity Pharmaceuticals, Inc.
nasdaq News
Nasdaq Place Get full coverage
  
  
six days ago at www.stocksnewspoint.com         
Hair-Raising Facts to Know about Companys 50 days simple moving average Arrowhead Pharmaceuticals .....
news
Stocks News Point SEC FORM 4 - SEC.gov SEC.gov Get full coverage
  
  
over a week ago at www.stocksgallery.com         
Infinity Pharmaceuticals, Inc. has a value of 1.72 per share While NanoViricides, Inc. is stand at 0...
news
Stocks Gallery Get full coverage
  
  
over a week ago at stockspen.com         
Acquisition by Jeffrey Berkowitz of 20000 shares of Infinity Pharmaceuticals subject to Rule 16b-3
news
Filed transaction by Infinity Pharmaceuticals director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
  
  
over a week ago at www.streetobserver.com         
Analysts said to Buy Healthcare Stock Infinity Pharmaceuticals, Inc.
news
Street Observer Get full coverage
  
  
over a week ago at kldaily.com         
Institutional Investors Positive on Infinity Pharmaceuticals Inc
news
KL DailyInfinity Pharmaceuticals Inc Institutional Investor Sentiment Is 1.32 The Malibu ReportInfinity Pharmaceuticals Inc Q1 2018 Sentiment Report Press Telegraph Get full coverage
  
  
over two weeks ago at www.zacks.com         
Infinity Pharmaceuticals Down 6.7 percent Since Earnings Report Can It Rebound
zacks News
Zacks.comRelative Strength Index Analysis Report Infinity Pharmaceuticals, Inc. , Knoll, Inc. CBRE Group, Inc. Is At 48.06 Formed Wedge Infinity Pharmaceuticals Has 1.32 Sentiment Technology Newsroom Get full coverage
  
  
over two weeks ago at www.thestreetpoint.com         
Staggering Stocks Novavax, Inc. , Infinity Pharmaceuticals, Inc. , Arcus Biosciences ...
Thestreet News
The Stock Street Get full coverage
  
  
over three weeks ago at usindexlive.com         
On Jun 1, 2018 Buy Rating Received Infinity Pharmaceuticals at Seaport Global with 4 Target.
news
US Index LiveOn Jun 1, 2018 Infinity Pharmaceuticals with 4 Target Was Coveraged By Seaport Global. The Casual SmartAlleghany Upped By 1.70 Million Its Grace WR Co Del New Stake Infinity Pharmaceuticals SI ... Wolcott Daily Get full coverage
  
  
over three weeks ago at thewellesleysnews.com         
Analyst Research and Ratings Infinity Pharmaceuticals, Inc. , Internap Corporation
news
Analyst Journal Get full coverage
  
  
over three weeks ago at www.stocksnewspoint.com         
Relative Strength Index in the Spotlight Infinity Pharmaceuticals, Inc. , Network-1 Technologies ...
news
Stocks News Point Is Buying Infinity Pharmaceuticals Inc Here Good Idea BZ WeeklyIs Infinity Pharmaceuticals Inc s Fuel Running High Reports Show Less Sellers Gldmn Blg Get full coverage
  
  
over a month ago at www.thewellesleysnews.com         
Influential Analyst Rating Changes Infinity Pharmaceuticals, Inc. , Nxstage Medical, Inc.
news
Analyst Journal Get full coverage
  

Build Optimal Portfolios

Diversify Your Portfolio With Infinity Pharmaceuticals
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Infinity Pharmaceuticals to your portfolio
Investors are also looking into
Emergent Capital exotic insider transaction detected
June 25, 2018 for Goldstein Phillip
Acquisition by Lowell Junkins of tradable shares of Federal Agricultural subject to Rule 16b 3
June 25, 2018 for Lowell Junkins
Exercise or conversion by George Kurian of 7020 shares of NetApp subject to Rule 16b 3
June 25, 2018 for George Kurian
View All Premium Stories  

Infinity Pharmaceuticals Performance

Performance against DOW
 Price Growth (%)  
      Timeline 
1
Analyst Research and Ratings Infinity Pharmaceuticals, Inc. ...05/31/2018
Please also check Infinity Pharmaceuticals Hype Analysis, Infinity Pharmaceuticals Correlation and Infinity Pharmaceuticals Performance. Please also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.